rs267607552
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_170707.4(LMNA):c.1380+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_170707.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LMNA | NM_170707.4 | c.1380+1G>A | splice_donor_variant, intron_variant | Intron 7 of 11 | ENST00000368300.9 | NP_733821.1 | ||
LMNA | NM_005572.4 | c.1380+1G>A | splice_donor_variant, intron_variant | Intron 7 of 9 | ENST00000677389.1 | NP_005563.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMNA | ENST00000368300.9 | c.1380+1G>A | splice_donor_variant, intron_variant | Intron 7 of 11 | 1 | NM_170707.4 | ENSP00000357283.4 | |||
LMNA | ENST00000677389.1 | c.1380+1G>A | splice_donor_variant, intron_variant | Intron 7 of 9 | NM_005572.4 | ENSP00000503633.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1Other:1
Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26688388, 18035086, 23349452, 22326558, 25525159, 27813223, 28436997, 31383942, 21846512) -
- -
Charcot-Marie-Tooth disease type 2 Pathogenic:1
This sequence change affects a donor splice site in intron 7 of the LMNA gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in LMNA are known to be pathogenic (PMID: 18585512, 18926329). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individuals with autosomal dominant laminopathies (PMID: 18035086, 22326558). This variant is also known as IVS7+1G>A. ClinVar contains an entry for this variant (Variation ID: 66817). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Cardiovascular phenotype Pathogenic:1
The c.1380+1G>A intronic pathogenic mutation results from a G to A substitution one nucleotide after coding exon 7 of the LMNA gene. This variant has been detected in multiple individual with dilated cardiomyopathy (DCM) and/or cardiac conduction defects, and co-segregation with disease has been reported in some families (van Tintelen JP et al. Am Heart J, 2007 Dec;154:1130-9; Millat G et al. Eur J Med Genet, 2011 Aug;54:e570-5; Jansweijer JA et al. Eur J Heart Fail, 2017 04;19:512-521; Park J et al. Genet Med, 2020 01;22:102-111). This variant has also been reported in an individual with DCM and limb-girdle muscular dystrophy (LGMD) (Magagnotti C et al. Biochim Biophys Acta, 2012 Jun;1822:970-9). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In silico splice site analysis predicts that this alteration will weaken the native splice donor site. Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Hutchinson-Gilford syndrome;C0410190:Emery-Dreifuss muscular dystrophy 2, autosomal dominant;C1449563:Dilated cardiomyopathy 1A;C1720860:Familial partial lipodystrophy, Dunnigan type;C1854154:Charcot-Marie-Tooth disease type 2B1;C2750035:Emery-Dreifuss muscular dystrophy 3, autosomal recessive;C2750785:Congenital muscular dystrophy due to LMNA mutation;C5399785:Mandibuloacral dysplasia with type A lipodystrophy Other:1
Variant interpreted as Pathogenic and reported on 09-29-2020 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at